
Randall L. Beane
Examiner (ID: 450, Phone: (571)270-3457 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 610 |
| Issued Applications | 172 |
| Pending Applications | 104 |
| Abandoned Applications | 347 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10050823
[patent_doc_number] => 09090691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences'
[patent_app_type] => utility
[patent_app_number] => 13/822435
[patent_app_country] => US
[patent_app_date] => 2011-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9333
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822435
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/822435 | Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences | Sep 14, 2011 | Issued |
Array
(
[id] => 8892448
[patent_doc_number] => 20130165632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'METHOD FOR SEPARATING WATER-SOLUBLE BIOLOGICAL SUBSTANCES'
[patent_app_type] => utility
[patent_app_number] => 13/820898
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6843
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820898
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820898 | METHOD FOR SEPARATING WATER-SOLUBLE BIOLOGICAL SUBSTANCES | Sep 8, 2011 | Abandoned |
Array
(
[id] => 9831935
[patent_doc_number] => 08940751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications'
[patent_app_type] => utility
[patent_app_number] => 13/821481
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17490
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1023
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821481
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/821481 | Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications | Sep 8, 2011 | Issued |
Array
(
[id] => 9263211
[patent_doc_number] => 20130345140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Basement Membrane Compositions and Applications Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/818904
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7559
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818904
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/818904 | Basement Membrane Compositions and Applications Thereof | Aug 24, 2011 | Abandoned |
Array
(
[id] => 9197634
[patent_doc_number] => 20130336950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/820377
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5630
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820377
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820377 | MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES | Aug 18, 2011 | Abandoned |
Array
(
[id] => 8301925
[patent_doc_number] => 20120184482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Novel Ubiquitin-Isopeptide Probes'
[patent_app_type] => utility
[patent_app_number] => 13/213667
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5777
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13213667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/213667 | Novel Ubiquitin-Isopeptide Probes | Aug 18, 2011 | Abandoned |
Array
(
[id] => 8842224
[patent_doc_number] => 20130137852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/813831
[patent_app_country] => US
[patent_app_date] => 2011-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10379
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813831
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813831 | NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOF | Aug 2, 2011 | |
Array
(
[id] => 11304813
[patent_doc_number] => 09512199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Fibronectin cradle molecules and libraries thereof'
[patent_app_type] => utility
[patent_app_number] => 13/813409
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 70
[patent_no_of_words] => 56856
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813409
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813409 | Fibronectin cradle molecules and libraries thereof | Jul 31, 2011 | Issued |
Array
(
[id] => 8951272
[patent_doc_number] => 20130197053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/810729
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/810729 | PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE | Jul 5, 2011 | Abandoned |
Array
(
[id] => 8607117
[patent_doc_number] => 20130012429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'ANTI-VIRAL THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/176994
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11664
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13176994
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/176994 | ANTI-VIRAL THERAPY | Jul 5, 2011 | Abandoned |
Array
(
[id] => 7670056
[patent_doc_number] => 20110319325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'MULTI-COMPONENT PHARMACEUTICALS FOR TREATING DIABETES'
[patent_app_type] => utility
[patent_app_number] => 13/169740
[patent_app_country] => US
[patent_app_date] => 2011-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13809
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/169740 | MULTI-COMPONENT PHARMACEUTICALS FOR TREATING DIABETES | Jun 26, 2011 | Abandoned |
Array
(
[id] => 8749474
[patent_doc_number] => 08415307
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-04-09
[patent_title] => 'Antibiotic compositions for the treatment of gram negative infections'
[patent_app_type] => utility
[patent_app_number] => 13/167495
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10812
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167495 | Antibiotic compositions for the treatment of gram negative infections | Jun 22, 2011 | Issued |
Array
(
[id] => 8278439
[patent_doc_number] => 20120172313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'TREATMENT OF PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/166960
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 23112
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166960
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166960 | TREATMENT OF PROLIFERATIVE DISEASES | Jun 22, 2011 | Abandoned |
Array
(
[id] => 8916354
[patent_doc_number] => 20130177979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'METHODS AND COMPOSITIONS FOR CELL PERMEABLE STAT3 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/806639
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31313
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806639
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806639 | METHODS AND COMPOSITIONS FOR CELL PERMEABLE STAT3 INHIBITOR | Jun 21, 2011 | Abandoned |
Array
(
[id] => 8964063
[patent_doc_number] => 20130203665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'SINGLE-CHAIN INSULIN AGONISTS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 13/701146
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 72905
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701146 | Single-chain insulin agonists exhibiting high activity at the insulin receptor | Jun 15, 2011 | Issued |
Array
(
[id] => 9162027
[patent_doc_number] => 20130310304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/704477
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10626
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704477
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/704477 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS | Jun 14, 2011 | Abandoned |
Array
(
[id] => 11799839
[patent_doc_number] => 09540634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Transcriptome in vivo analysis'
[patent_app_type] => utility
[patent_app_number] => 13/702415
[patent_app_country] => US
[patent_app_date] => 2011-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12717
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702415
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/702415 | Transcriptome in vivo analysis | Jun 6, 2011 | Issued |
Array
(
[id] => 8733716
[patent_doc_number] => 20130079285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/700623
[patent_app_country] => US
[patent_app_date] => 2011-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16313
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700623
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700623 | SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME | May 29, 2011 | Abandoned |
Array
(
[id] => 9401719
[patent_doc_number] => 08691771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Bi-specific fusion proteins for tissue repair'
[patent_app_type] => utility
[patent_app_number] => 13/112907
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14807
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112907 | Bi-specific fusion proteins for tissue repair | May 19, 2011 | Issued |
Array
(
[id] => 8854128
[patent_doc_number] => 20130143803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'Process for the Preparation of Insulin-Zinc Complexes'
[patent_app_type] => utility
[patent_app_number] => 13/696897
[patent_app_country] => US
[patent_app_date] => 2011-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8654
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/696897 | Process for the Preparation of Insulin-Zinc Complexes | May 8, 2011 | Abandoned |